Lupus Clinical Trials in Phoenix

Showing 61-80 of 100 trials

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

NCT03061071

This study is a prospective, multi-center, randomized crossover of the NightBalance SPT compared to APAP for the treatment of Positional Obstructive Sleep Apnea (POSA).

Sleep Apnea Syndromes

NightBalance117 participantsStarted Mar 2017

Birmingham, Alabama, United States • Glendale, Arizona, United States • Gainesville, Florida, United States +8 more locations

COMPLETEDPHASE2/PHASE39.5 miles

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

NCT00137969

This is a Phase II/III, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of rituximab compared with placebo when combined with a single stable background immunosuppressive medication in subjects with moderate to severe systemic lupus erythematosus (SLE). The primary efficacy endpoint of the trial will be evaluated at 52 weeks.

Lupus Erythematosus, Systemic

Genentech, Inc.262 participantsStarted May 2005

Birmingham, Alabama, United States • Huntsville, Alabama, United States • Paradise Valley, Arizona, United States +62 more locations

The POSAtive Study: Study for the Treatment of Positional Obstructive Sleep Apnea

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

Lupus Trials in Other Cities

A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)

A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus

A Study of Belimumab in Subjects With Systemic Lupus Erythematosus

This Study Assesses the Impact of Different Sheets on Body Temperature and Sleep

A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis

Immunogenicity and Safety of GSK Biologicals' Combined Measles-mumps-rubella Vaccine in Volunteers, Seven Years of Age and Older

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Subjects Four to Six Years of Age

A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus

Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus

Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus

MSC2364447C Phase 1b in Systemic Lupus Erythematosus

A 4-Week Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in Subjects With Parkinson's Disease and Excessive Sleepiness

A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus

A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

Safety Study of AMG 557 in Subjects With Lupus Arthritis

Comparison of SomnaPatch With Polysomnography in Sleep Disordered Breathing

Other Conditions in Phoenix